Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Ono terminates CholestaGel agreement with GelTex

July 5, 1996

Fortical phase I dosing data revised

July 5, 1996

HHS scientist discovers cartilage formation stimulant

July 5, 1996

Vasodilator cream shows positive results in trials

June 28, 1996

Zonagen's Vasomax covered under U.S. patent

June 28, 1996

Merck & Co. reveals growth hormone release promoters

June 28, 1996

Exocell granted U.S. patent for A717

June 28, 1996

Sankyo to file NDA for Noscal

June 28, 1996

HemAssist to enter phase III

June 28, 1996

SomatoKine covered under U.S. patent

June 28, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 29, 2025
New drugs with the same old resistance tricks?
BioWorld
According to the World Health Organization (WHO), multidrug-resistant pathogens caused over 1.27 million deaths worldwide in 2020. And figures are rising, with...
Vilastobart set apart? Xilio phase II combo performs in CRC
BioWorld
“The [colorectal cancer field is moving, and thankfully it’s moving quickly,” said Marwan Fakih, gastrointestinal specialist at City of Hope, speaking about...
Novo weight-loss data roll out; Veru ‘leans’ in
BioWorld
As investors look ahead to data shortly from Veru Inc. with enobosarm, the weight-loss space remains hot, with Novo Nordisk A/S reporting favorable top-line...